Here are four trends:
1. The market is expected to grow at a compound annual growth rate of 7 percent.
2. The market is driven by various factors, including the increase in eye-related disorders and regulatory approvals to new drugs and devices.
3. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hinder the market growth.
4. Top players in the market include Abbot Laboratories, Johnson & Johnson, Alcon, Allergan and Bausch & Lomb.
More articles on ASC issues:
Americans are online — And they want healthcare information: 6 key notes
Canadian and US researchers explore social media in public health — 5 observations
12 statistics and facts on ophthalmology and ophthalmologists
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.